Alex successfully applied for an Irish Cancer Society international mobility element, which afforded her the opportunity to spend three months in the Albert Einstein College of Medicine, New York. She was mentored by an expert in the field of Epigenetics, Prof John Greally, in order to learn how to computationally catalogue enhancer activity in prostate cancer.
-
Cancer Research News- NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients April 18, 2024
- For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life March 7, 2024
- Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges March 6, 2024
- NIH to address dwindling clinical trial patient enrollment with centralized staffing support February 29, 2024
- NIH launches research network to evaluate emerging cancer screening technologies February 21, 2024
- W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute December 18, 2023
- NCI researchers develop approach that could help supercharge T-cell therapies against solid tumors November 1, 2023
- NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation October 24, 2023
- Annual Report to the Nation Part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic September 27, 2023
- NCI unveils comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries August 14, 2023